Search

Your search keyword '"Chokshi, Shilpa"' showing total 309 results

Search Constraints

Start Over You searched for: Author "Chokshi, Shilpa" Remove constraint Author: "Chokshi, Shilpa"
309 results on '"Chokshi, Shilpa"'

Search Results

1. Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

2. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

3. Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease

4. Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

6. SAT-467 Prioritisation of research to tackle stigma in alcohol-related liver disease: results from the ARMS-Hub partnership

7. WED-542-YI Unravelling bacterial metabolites using high-resolution magic angle spinning nuclear magnetic resonance spectroscopy in intact hepatocellular carcinoma liver tissue

8. THU-320-YI The pan-cyclophilin inhibitor rencofilstat exhibits therapeutic anti-fibrotic effects in human relevant models of alcohol-related liver disease via extracellular matrix remodelling

9. WED-068-YI Cell-free DNA dynamics in advanced cirrhosis: unravelling the role of nuclear and mitochondrial DNA in inflammation, coagulation dysfunction and short-term mortality

10. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

11. TOP-084 Galectin 9 predicts clinical outcome and regulates immune dysfunction in acute-on-chronic liver failure

12. OS-091 Precision-cut liver slices as a pre-clinical model for the evaluation of host-targeting agents against hepatitis B virus and hepatitis delta virus infection

14. Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease

15. High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region.

17. Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease

18. The British Association for the Study of the Liver commitment to equality, diversity, and inclusivity

23. Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity

27. Cyclophilin inhibition exhibits preventive and curative antifibrotic effects via extracellular matrix remodelling

28. Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease.

30. Giant mitochondria in human liver disease.

33. P26 Circulating markers of neutrophil extracellular traps are associated with excessive coagulation activation in decompensated cirrhosis and acute-on-chronic liver failure

34. Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

36. In-depth shotgun metagenomic analysis of the oral and gut microbiome identifies striking overlap in microbial community structure, virulence factors and antimicrobial resistance genes based on stage and severity of cirrhosis

37. A bioengineered approach to re-create and study the extracellular matrix-immune cell crosstalk in normal and fibrotic liver

38. Cyclophilin inhibitor CRV431 as a potential therapy for alcohol-related liver disease

39. Predictive immune biomarkers to safely discontinue nucleos (t)ide analogue treatment in HBeAg negative chronic hepatitis B (NUC-B study)

40. Dynamic organotypic culture of primary liver cancer as a personalised immunocompetent drug screening platform for immuno-oncology

41. Circulating cell-free DNA levels increment with worsening cirrhosis severity and associate with platelet exhaustion and mortality

44. TOP-553 Deciphering the immunological dynamics of flares following nucleos (t)ide analogue (NA) cessation in HBeAg negative chronic hepatitis B in a large, longitudinal, phase II multi-centred clinical trial (NUC-B study)

45. The Diversity and Management of Chronic Hepatitis B Virus Infections in the United Kingdom: A Wake-up Call

46. In-depth shotgun metagenomic analysis of the oral and gut microbiome identifies striking overlap in microbial community structure, virulence factors and antimicrobial resistance genes based on stage and severity of cirrhosis

47. A review of alcohol–pathogen interactions: New insights into combined disease pathomechanisms

48. ISBRA Communications Bulletin Vol 3 issue 6 2021

49. BulletinISBRAVol4Issue1 Publication2022

50. ISBRA Communications Bulletin Vol 4 issue 2 2022

Catalog

Books, media, physical & digital resources